With ubituximab, a high percentage of patients maintained no signs of disease activity.

Published Date: 01 Mar 2023

After receiving ublituximab treatment, the majority of patients with relapsing multiple sclerosis showed that they could achieve and maintain no evidence of disease activity.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Month-Long Wait Times Caused by US Physician Shortage.

2.

Certain surgical gestures during prostate removal linked to better sexual function recovery

3.

A better option for mild to moderate depression?

4.

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

5.

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot